Thierry Lecomte
Université de Tours(FR)Inserm(FR)Sorbonne Université(FR)Hôpital Armand-Trousseau(FR)Centre Hospitalier Universitaire de Tours(FR)Groupe d'Oncologie Radiothérapie Tête et Cou(FR)Hôpital Bretonneau(FR)Institut Universitaire en Santé Mentale de Québec(CA)Thion Medical (France)(FR)
Publications by Year
Research Areas
Colorectal Cancer Treatments and Studies, Gastric Cancer Management and Outcomes, Pancreatic and Hepatic Oncology Research, Genetic factors in colorectal cancer, Neuroendocrine Tumor Research Advances
Most-Cited Works
- → FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer(2018)2,781 cited
- → Icy: an open bioimage informatics platform for extended reproducible research(2012)1,585 cited
- → Analysis of PTEN , BRAF , and EGFR Status in Determining Benefit From Cetuximab Therapy in Wild-Type KRAS Metastatic Colon Cancer(2009)665 cited
- → Presentation and Long-Term Follow-up of Refractory Celiac Disease: Comparison of Type I With Type II(2008)370 cited
- → Detection of free‐circulating tumor‐associated DNA in plasma of colorectal cancer patients and its association with prognosis(2002)297 cited
- → Five-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic Cancer(2022)295 cited